PP London Sumatra Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? PP London Sumatra Indonesia Tbk. trades at Rp1,335 (market cap 9.04T, 3.96M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: PP London Sumatra Indonesia Tbk. is far larger — about 54× Brigit Biofarmaka Teknologi Tbk.'s market cap, and PP London Sumatra Indonesia Tbk. is more actively traded (3.96M versus 96.7K). Which is the better fit depends on your goals.
| LSIP | OBAT | |
|---|---|---|
Market Cap | 9.04T | 167.37B |
Volume | 3.96M | 96.7K |
Lot | 39.64K | 967 |
Turnover | 5.28B | 23.82M |
Average Price | 1,333.35 | 246.34 |
Value | 5.28B | 23.82M |
Indicative Equilibrium Price | 1,335 | 248 |
Indicative Equilibrium Volume | 139 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Perusahaan Perkebunan London Sumatera Tbk abbreviated as Lonsum, was established in teh Republic of Indonesia based on Notarial Deed No. 93 of Raden Kadiman dated December 18, 1962 and amended by Notarial Deed No. 20 dated September 9, 1963. Based on Notarial Deed No. 18 of Pahala Sutrisno Amijoyo Tampubolon, S.H., M.Kn., dated May 24, 2013, the Company's shareholders approved the change of the Company's status from Foreign Capital Investment (PMA) company to Domestic Capital Investment (PMDN) company.
Read more on LSIP →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →